RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 79 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,507,534 | +8.3% | 61,070 | +14.3% | 0.00% | 0.0% |
| Q1 2024 | $2,315,122 | -7.4% | 53,430 | -1.8% | 0.00% | 0.0% |
| Q4 2023 | $2,500,308 | +100.5% | 54,390 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $1,246,891 | +39.0% | 54,390 | 0.0% | 0.00% | – |
| Q2 2023 | $896,891 | +73.5% | 54,390 | +21.1% | 0.00% | – |
| Q1 2022 | $517,000 | +15.7% | 44,900 | +0.2% | 0.00% | – |
| Q4 2021 | $447,000 | -17.7% | 44,800 | +7.7% | 0.00% | – |
| Q3 2021 | $543,000 | -33.4% | 41,600 | 0.0% | 0.00% | – |
| Q2 2021 | $815,000 | -7.9% | 41,600 | 0.0% | 0.00% | – |
| Q1 2021 | $885,000 | -25.8% | 41,600 | +3.7% | 0.00% | -100.0% |
| Q4 2020 | $1,192,000 | +37.2% | 40,100 | 0.0% | 0.00% | – |
| Q3 2020 | $869,000 | -5.6% | 40,100 | -2.9% | 0.00% | -100.0% |
| Q2 2020 | $921,000 | +148.2% | 41,300 | +69.3% | 0.00% | – |
| Q1 2020 | $371,000 | -33.8% | 24,400 | 0.0% | 0.00% | – |
| Q4 2019 | $560,000 | +11.8% | 24,400 | +5.2% | 0.00% | – |
| Q3 2019 | $501,000 | +21.9% | 23,200 | +24.1% | 0.00% | – |
| Q2 2019 | $411,000 | -4.4% | 18,700 | +19.1% | 0.00% | – |
| Q1 2019 | $430,000 | -3.6% | 15,700 | -5.4% | 0.00% | – |
| Q4 2018 | $446,000 | +20.5% | 16,600 | +30.7% | 0.00% | – |
| Q3 2018 | $370,000 | +62.3% | 12,700 | +74.0% | 0.00% | – |
| Q2 2018 | $228,000 | – | 7,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Checkpoint Capital L.P. | 825,500 | $35,768,915 | 23.90% |
| NEA Management Company, LLC | 2,909,956 | $126,088,393 | 7.83% |
| Opaleye Management Inc. | 515,000 | $22,314,950 | 4.86% |
| Frazier Life Sciences Management, L.P. | 2,190,179 | $94,900,456 | 4.00% |
| Baker Brothers Advisors | 6,398,365 | $277,241,155 | 3.48% |
| COMMODORE CAPITAL LP | 1,050,000 | $45,496,500 | 3.04% |
| JGP Global Gestao de Recursos Ltda. | 105,814 | $4,584,921 | 2.95% |
| RA Capital Management | 5,330,412 | $230,966,752 | 2.94% |
| Perceptive Advisors | 3,268,579 | $141,627,528 | 2.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 183,776 | $7,963,014 | 2.21% |